Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide

Aim: To research the synergistic activity of G2-S16 dendrimer and dapivirine (DPV) antiretroviral as microbicide candidate to prevent HIV-1 infection. Materials & methods: We assess the toxicity of DPV on cell lines by MTT assay, the anti-HIV-1 activity of G2-S16 and DPV alone or combined at several fixed ratios. Finally, their ability to inhibit the bacterial growth in vitro was assayed. The analysis of combinatorial effects and the effective concentrations were performed with CalcuSyn software. Conclusion: Our results represent the first proof-of-concept study of G2-S16/DPV combination to develop a safe microbicide.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Future medicinal chemistry - 11(2019), 23 vom: 06. Dez., Seite 3005-3013

Sprache:

Englisch

Beteiligte Personen:

Guerrero-Beltrán, Carlos [VerfasserIn]
Prieto, AnabeI [VerfasserIn]
Leal, Manuel [VerfasserIn]
Jiménez, José Luis [VerfasserIn]
Muñoz-Fernández, M Ángeles [VerfasserIn]

Links:

Volltext

Themen:

Anti-HIV Agents
Carbosilane
Dapivirine
Dendrimers
G2-S16 dendrimer
HIV-1
Journal Article
Microbicide
Polyanions
Polyelectrolytes
Polymers
Pyrimidines
Research Support, Non-U.S. Gov't
Silanes
TCN4MG2VXS

Anmerkungen:

Date Completed 15.07.2020

Date Revised 04.12.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.4155/fmc-2018-0539

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM30313996X